Literature DB >> 29074500

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights.

Amrom E Obstfeld1, Noelle V Frey2,3, Keith Mansfield4, Simon F Lacey1,5, Carl H June1,5, David L Porter2,3, Jan J Melenhorst1,5, Mariusz A Wasik1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29074500     DOI： 10.1182/blood-2017-08-802413

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  41 in total

1.  Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice.

Authors:  Christopher A Pennell; Jessie L Barnum; Cameron S McDonald-Hyman; Angela Panoskaltsis-Mortari; Megan J Riddle; Zhengming Xiong; Michael Loschi; Govindarajan Thangavelu; Heather M Campbell; Meghan D Storlie; Yosef Refaeli; Scott N Furlan; Michael C Jensen; Leslie S Kean; Jeffrey S Miller; Jakub Tolar; Mark J Osborn; Bruce R Blazar
Journal:  Mol Ther       Date:  2018-04-07       Impact factor: 11.454

Review 2.  Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.

Authors:  Sarju Ganatra; Joseph R Carver; Salim S Hayek; Bonnie Ky; Monika J Leja; Daniel J Lenihan; Carrie Lenneman; Negaresh Mousavi; Jae H Park; Miguel Angel Perales; Thomas D Ryan; Marielle Scherrer-Crosbie; Richard M Steingart; Eric H Yang; Vlad Zaha; Ana Barac; Jennifer E Liu
Journal:  J Am Coll Cardiol       Date:  2019-12-24       Impact factor: 24.094

3.  Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.

Authors:  Naoki Kurita; Tatsuhiro Sakamoto; Takayasu Kato; Manabu Kusakabe; Yasuhisa Yokoyama; Hidekazu Nishikii; Mamiko Sakata-Yanagimoto; Naoshi Obara; Yuichi Hasegawa; Shigeru Chiba
Journal:  Ann Hematol       Date:  2021-02-12       Impact factor: 3.673

4.  Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy.

Authors:  Pei-Hsuan Chen; Mikel Lipschitz; Jason L Weirather; Caron Jacobson; Philippe Armand; Kyle Wright; F Stephen Hodi; Zachary J Roberts; Stuart A Sievers; John Rossi; Adrian Bot; William Go; Scott J Rodig
Journal:  JCI Insight       Date:  2020-06-18

Review 5.  Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment.

Authors:  Ibrahim Aldoss; Samer K Khaled; Elizabeth Budde; Anthony S Stein
Journal:  Curr Oncol Rep       Date:  2019-01-21       Impact factor: 5.075

Review 6.  Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies.

Authors:  Juliane Gust; Agne Taraseviciute; Cameron J Turtle
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 7.  Role of T cell-derived exosomes in immunoregulation.

Authors:  Jian Lu; Jing Wu; Jie Tian; Shengjun Wang
Journal:  Immunol Res       Date:  2018-06       Impact factor: 4.505

8.  Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.

Authors:  Sabina Kaczanowska; Daniel W Beury; Vishaka Gopalan; Arielle K Tycko; Haiying Qin; Miranda E Clements; Justin Drake; Chiadika Nwanze; Meera Murgai; Zachary Rae; Wei Ju; Katherine A Alexander; Jessica Kline; Cristina F Contreras; Kristin M Wessel; Shil Patel; Sridhar Hannenhalli; Michael C Kelly; Rosandra N Kaplan
Journal:  Cell       Date:  2021-03-24       Impact factor: 66.850

9.  IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors.

Authors:  Hannah M Knochelmann; Connor J Dwyer; Aubrey S Smith; Jacob S Bowers; Megan M Wyatt; Michelle H Nelson; Guillermo O Rangel Rivera; Joshua D Horton; Carsten Krieg; Kent Armeson; Gregory B Lesinski; Mark P Rubinstein; Zihai Li; Chrystal M Paulos
Journal:  Cancer Res       Date:  2020-06-19       Impact factor: 12.701

10.  Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation.

Authors:  Yunshuo Chen; Ranran Li; Siqi Shang; Xuejiao Yang; Lei Li; Wenbo Wang; Yueying Wang
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.